Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Intra-Anal Isosorbide Mononitrate Gel
NCT04729088Phase 1Withdrawn
- Sponsor
- Biolab Farmacêutica
- Start
- Dec 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of isosorbide mononitrate in anal fissure, sponsored by Biolab Farmacêutica. Primary endpoints: Area under the plasma concentration versus time curve from time zero to last at 36 hours, Area under the plasma concentration versus time curve from time zero to infinite at 36 hours and 4 more. Planned start Dec 2020; status: withdrawn.
02
Drugs
isosorbide mononitrate
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT04729088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729088.